The first report of a mutation in EIF2AK4 reponsible for hereditary pulmonary arterial hypertension came as a combined heterozygous mutation in conjunction with a BMPR2 mutation [22]. Here, EIF2AK4 is linked to pulmonary arterial hypertension.